-Live Mint Cipla Ltd won a landmark patent case against Swiss drug maker F Hoffmann-La Roche Ltd in the Delhi high court on Friday over the Indian company’s generic copy of lung cancer drug Tarceva after a four-year court battle. Justice Manmohan Singh observed in his 280-page judgement that it had been scientifically proven that Cipla’s generic version was a polymorph B variant of Roche’s patented drug and that it didn’t actually...
More »SEARCH RESULT
Total Matching Records found : 283
Patients lose out to patents & profits -Deepa Kurup
-The Hindu A 2012 WHO study ranks India third — behind Myanmar and Bangladesh — among countries that fail to provide health cover to people. A 2011 study reported in The Lancet on ‘Healthcare and equity’ confirms this: every year, at least 39 million people here fall into poverty due to private out-of-pocket health expenditure. A vast majority of Indians do not have access to healthcare or essential drugs. By the...
More »Cancer, HIV patients suffer as morphine supplies are hobbled by excessive regulation
-The Economic Times MUMBAI: India, the world's largest exporter of morphine sulphate, has very little of the drug to offer its terminally ill patients suffering from cancer and HIV. The supply of morphine, a narcotic pain reliever used for treating pain, is severely constrained in local hospitals and retail stores due to stringent laws that prevent and hinder companies from making and transporting the final product. Morphine sulphate is a byproduct of...
More »1144 Deaths During Clinical Drug Trials in 2 Years: Govt
-PTI Clinical drug trials in India led to the death of 1144 people in 2010 and 2011, the government today said. The number of people dying during such trials also include 1106 people whose death could be attributed to diseases like cancer, terminal illness or various unrelated causes which is also known as Serious Adverse Event (SAE) of death, Health and Family Welfare Minister Ghulam Nabi Azad told the Rajya Sabha. "The number...
More »Lack of compensation norms for clinical trials results in exploitation of poor patients-Khomba Singh
-The Economic Times Drug companies paid as little as 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing clamour among health groups for more stringent guidelines on new drug trials. According to government data accessed by a healthcare activist through an RTI query, Germany's Fresenius Kabi paid 50,000 each to the...
More »
